Background: Transcatheter closure of a perimembranous ventricular septal defect (PmVSD)
is usually performed with an asymmetric Amplatzer occluder, which is not an ideal device …

Background: Perimembranous ventricular septal defect (VSD) is the most common
congenital heart defect. Percutaneous transcatheter closure of VSD is one of the greatest …

Objective: To close perimembranous ventricular septal defects (PMVSDs) in children with
the new Amplatzer asymmetric ventricular septal defect occluder (AAVSDO). Patients and …

Objectives: This study assessed the feasibility and efficacy of implanting a new nitinol device
for closure of perimembranous ventricular septal defects in a swine model. Background …

Objective: To report the immediate and midterm results of transcatheter closure of
perimembranous ventricular septal defect (PmVSD) using the Amplatzer membranous VSD …

There are very few published reports of the transcatheter closure of perimembranous
ventricular septal defects (PMVSDs) using the Amplatzer PMVSD occluder with encouraging …

Percutaneous closure of perimembranous ventricular septal defects (VSDs) has been
feasible, safe, and effective with the new Amplatzer membranous septal occluder. We report …

Objectives To describe the initial world experience and mid‐term follow‐up of
perimembranous ventricular septal defect (pmVSD) closure with a newly designed occluder …

OBJECTIVE: The development of the Amplatzer Membranous VSD Occluder (AGA Medical
Corp, Plymouth, Minn) for closure of the perimembranous ventricular septal defect has …

Using an Amplatzer membranous eccentric occluder, 186 patients with an average weight of
43.5 kg (range 12.5–77) underwent attempted catheter closure of a perimembranous …